Overview

Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:
0

Participant gender:
All

Summary

Study to investigate the safety and efficacy of Alesion® Dry Syrup under the proper use in daily clinical practice in Japanese paediatric patients with urticaria

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Epinastine

Criteria

Inclusion Criteria:

- All the patients who:

- haven't treatment experience of epinastine product entered the survey;

- have urticaria

Exclusion Criteria:

- Alesion® Dry Syrup is contraindicated for the patients with history of
hypersensitivity to any ingredients of Alesion® Dry Syrup in package insert. However,
it was unknown whether a patient is hypersensitive to the ingredients of the product
in almost cases. And this survey was drug utilization study to observe actual use in
any patients. Therefore exclusion criteria are not set in the protocol